ES2036171T3 - Isonitrilos eter y complejos radiomarcados de los mismos. - Google Patents

Isonitrilos eter y complejos radiomarcados de los mismos.

Info

Publication number
ES2036171T3
ES2036171T3 ES86117847T ES86117847T ES2036171T3 ES 2036171 T3 ES2036171 T3 ES 2036171T3 ES 86117847 T ES86117847 T ES 86117847T ES 86117847 T ES86117847 T ES 86117847T ES 2036171 T3 ES2036171 T3 ES 2036171T3
Authority
ES
Spain
Prior art keywords
isonitrils
ether
radio
complexes
marked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86117847T
Other languages
English (en)
Inventor
Paul Louis Bergstein
Vinayakam Subramanyam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27123612&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2036171(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of ES2036171T3 publication Critical patent/ES2036171T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/10—Isocyanides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Position Fixing By Use Of Radio Waves (AREA)

Abstract

ISONITRILOS SUSTITUIDOS CON ETERES, COMPLEJOS TC99M DE LOS MISMOS Y PROCEDIMIENTO PARA OBTENER RADIOIMAGENES DEL TEJIDO DEL MIOCARDIO USANDO LOS COMPLEJOS TC99M.
ES86117847T 1985-12-23 1986-12-20 Isonitrilos eter y complejos radiomarcados de los mismos. Expired - Lifetime ES2036171T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81247085A 1985-12-23 1985-12-23
US92509186A 1986-11-06 1986-11-06

Publications (1)

Publication Number Publication Date
ES2036171T3 true ES2036171T3 (es) 1996-07-16

Family

ID=27123612

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86117847T Expired - Lifetime ES2036171T3 (es) 1985-12-23 1986-12-20 Isonitrilos eter y complejos radiomarcados de los mismos.

Country Status (20)

Country Link
US (1) US4988827A (es)
EP (1) EP0233368B1 (es)
JP (2) JPH0755914B2 (es)
KR (1) KR940011456B1 (es)
CN (1) CN1057470C (es)
AU (1) AU594407B2 (es)
CA (1) CA1305160C (es)
DE (1) DE3673000D1 (es)
DK (1) DK173003B1 (es)
ES (1) ES2036171T3 (es)
FI (1) FI91747C (es)
GR (1) GR3000681T3 (es)
HU (1) HU201301B (es)
ID (1) ID1037B (es)
IE (1) IE59758B1 (es)
IL (1) IL81055A (es)
MX (1) MX168821B (es)
NO (1) NO166640C (es)
PT (1) PT83996B (es)
SU (1) SU1635903A3 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885100A (en) * 1987-09-11 1989-12-05 E. I. Du Pont De Nemours And Company Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes
US5008418A (en) * 1987-09-11 1991-04-16 E. I. Du Pont De Nemours And Company Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes
US5028699A (en) * 1987-09-11 1991-07-02 E. I. Du Pont De Nemours And Company Process for preparing Tc-99m tris(isonitrile) copper complexes
US4864051A (en) * 1988-09-02 1989-09-05 E. R. Squibb & Sons, Inc. Process for preparing 2-methoxyisobutylisonitrile
EP0548245A1 (en) * 1990-06-18 1993-06-30 Mallinckrodt Medical, Inc. Metal-radionuclide complex comprising isonitrile ligands
US5210270A (en) * 1991-11-25 1993-05-11 Institute Of Nuclear Energy Research Method for synthesis and 99m C labelling of 2-alkoxyisobutylisonitrile
US5420321A (en) * 1993-08-03 1995-05-30 The Du Pont Merck Pharmaceutical Company Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes
DE4445004A1 (de) * 1994-12-16 1996-06-20 Consortium Elektrochem Ind Zusammensetzung zur delokalisierten Kennzeichnung von Gegenständen, ihre Herstellung und Verwendung
US5961952A (en) * 1996-01-24 1999-10-05 Dupont Pharmaceuticals Company 99m Tc-tertiary-butyl isonitrile as breast tumor imaging agents
US6416733B1 (en) * 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US20030124053A1 (en) * 1996-10-07 2003-07-03 Barrett John Andrew Radiopharmaceuticals for imaging infection and inflammation
US6524553B2 (en) * 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) * 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
JP2002510705A (ja) 1998-04-03 2002-04-09 デュポン ファーマシューティカルズ カンパニー 感染および炎症の撮像、ならびに癌の撮像および治療のための放射性医薬品
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6511648B2 (en) 1998-12-18 2003-01-28 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
WO2000035887A2 (en) * 1998-12-18 2000-06-22 Du Pont Pharm Co Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) * 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6656448B1 (en) 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
AU2001261728A1 (en) * 2000-05-17 2001-11-26 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
AU783857B2 (en) * 2000-06-01 2005-12-15 Bristol-Myers Squibb Pharma Company Lactams substituted by cyclic succinates as inhibitors of a beta protein production
US6770259B2 (en) 2000-11-03 2004-08-03 Bristol-Myers Squibb Pharma Company Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
CN1136921C (zh) * 2001-04-27 2004-02-04 北京师范大学 一种心肌显像剂及其制备方法
US20090062256A1 (en) * 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
EP1423152A4 (en) * 2001-08-08 2006-12-27 Bristol Myers Squibb Pharma Co SIMULTANEOUS PRESENTATION OF THE HEART PERFUSION AND IMAGING MEDICINE WITH VITRONECTIN RECEPTOR AS TARGET
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20070014721A1 (en) * 2005-06-30 2007-01-18 Harris Thomas D Hydrazide conjugates as imaging agents
WO2007123934A2 (en) * 2006-04-19 2007-11-01 The General Hospital Corporation Aryl bidentate isonitriles and their uses
CA2612656A1 (en) * 2006-10-30 2008-04-30 Draxis Specialty Pharmaceuticals Inc. Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(i) tetrafluoroborate
EP2821394A1 (en) * 2013-07-01 2015-01-07 Fundacion MEDINA. Centro de Excelencia en Investigacion de Medicamentos Innovadores en Andalucia Compounds with antibacterial activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215142B (de) * 1964-07-09 1966-04-28 Bayer Ag Verfahren zur Herstellung von araliphatischen Isonitrilen
GB1187755A (en) * 1968-02-24 1970-04-15 Bayer Ag A Process for the Production of Isonitriles
DE1962898A1 (de) * 1969-12-16 1971-06-24 Bayer Ag Verfahren zur Herstellung von Isonitrilen
JPS57165370A (en) * 1981-03-18 1982-10-12 Ici Ltd Triazole or imidazole compounds, manufacture and fungicidal or plant growth regulant agent
US4347251A (en) * 1981-07-13 1982-08-31 American Cyanamid Company Novel 3-substituted amino-1-substituted heteroaryl-2-pyrazolines
US4452774A (en) * 1982-04-30 1984-06-05 President And Fellows Of Harvard College Isonitrile radionuclide complexes for labelling and imaging agents
DE3343673A1 (de) * 1983-12-02 1985-09-05 Basf Ag, 6700 Ludwigshafen Verfahren zur gleichzeitigen herstellung von nitrilen und acrylamid bzw. methacrylamid
US4707544A (en) * 1984-11-28 1987-11-17 President And Fellows Of Harvard College Metal-isonitrile adducts for preparing radionuclide complexes for labelling and imaging agents
US4735793A (en) * 1985-08-30 1988-04-05 Massachusetts Institute Of Technology Carboxy, carboalkoxy and carbamile substituted isonitrile radionuclide complexes

Also Published As

Publication number Publication date
IL81055A (en) 1991-07-18
ID1037B (id) 1996-10-24
PT83996A (en) 1987-01-01
HUT43557A (en) 1987-11-30
MX168821B (es) 1993-06-10
GR3000681T3 (en) 1991-09-27
NO865247L (no) 1987-06-24
DK623886D0 (da) 1986-12-22
IE863353L (en) 1987-06-23
FI865260A0 (fi) 1986-12-22
DK173003B1 (da) 1999-11-01
CA1305160C (en) 1992-07-14
IL81055A0 (en) 1987-03-31
FI91747C (fi) 1994-08-10
JPS62201363A (ja) 1987-09-05
AU6684286A (en) 1987-06-25
EP0233368B1 (en) 1990-07-25
SU1635903A3 (ru) 1991-03-15
NO865247D0 (no) 1986-12-22
US4988827A (en) 1991-01-29
FI91747B (fi) 1994-04-29
KR940011456B1 (ko) 1994-12-15
KR870005976A (ko) 1987-07-08
CN1057470C (zh) 2000-10-18
JPH07242615A (ja) 1995-09-19
NO166640B (no) 1991-05-13
DK623886A (da) 1987-06-24
JP2774940B2 (ja) 1998-07-09
NO166640C (no) 1991-08-21
DE3673000D1 (de) 1990-08-30
PT83996B (pt) 1989-07-31
IE59758B1 (en) 1994-03-23
AU594407B2 (en) 1990-03-08
CN1057585A (zh) 1992-01-08
HU201301B (en) 1990-10-28
EP0233368A1 (en) 1987-08-26
JPH0755914B2 (ja) 1995-06-14
FI865260A (fi) 1987-06-24

Similar Documents

Publication Publication Date Title
ES2036171T3 (es) Isonitrilos eter y complejos radiomarcados de los mismos.
AR211109A1 (es) Procedimiento para la obtencion del antibiotico tienamicina.
NL186431B (nl) Meercellige roentgenstralingsdetector.
ES519559A0 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
MX3830E (es) Procedimiento para la preparacion de eteres de oxima
IT7822131A0 (it) Tubo rontgen girevole.
IT7822464A0 (it) Procedimento per preparare trifluoruro di azoto.
IT7823439A0 (it) Procedimento per produrre eteri carbossilati.
MX5934E (es) Procedimiento para la preparacion de 1-substituido-4,5-diaril-2-(tiosubstituido)imidazoles
TR17737A (tr) Halojenlenmis 4-triflorometil-difenil-(tio)eterler,bunlarin hazirlanmasina mahsus usuller ve bunlarin herbisid olarak kullanilmalari
MX7284E (es) Procedimiento mejorado para la obtencion de una olefina por descomposicion del eter correspondiente
IT7827871A0 (it) Procedimento di preparazione di serinolo.
MX7046E (es) Procedimiento mejorado para elaborar almidones quimicamente modificados,empleando radiacion de ultra alta frecuencia
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
NL7800011A (nl) Cyclische ethers.
NL7703294A (nl) Roentgendetektor.
NL7801734A (nl) Benzyloxim-ethers.
IT1000506B (it) Procedimento per la preparazione del floroglucinolo del suo etere monometilico e di diidrossibenzeni
SE7811593L (sv) 2,4-diamino-5-bensylpyrimidiner och forfarande for framstellning derav
AR221735A1 (es) Procedimiento para la obtencion del nuevo 6-isoticiano 5-metoxi-2-ter-butil-benzotiazol
ES496332A0 (es) Procedimiento para la obtencion de 10-oxo-10-11,dihidro-5h- dibenz(b,f)azepin-3-carboxamida
NL177541C (nl) Inbouw-antennecontactdoos.
IT1196398B (it) Procedimento per produrre eteri bis (n,(-dialchilammino) alchilici
IT7824056A0 (it) Processo per la preparazione di eteri del bufadienolide e delbufatrienolide.
ES518213A0 (es) Procedimiento para la obtencion del perclorometilmercaptano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0233368

Country of ref document: ES